Newswire

Patients Often Lose in the Battle between Pharma and PBMs

FTC Deepens Inquiry into Prescription Drug Middlemen

Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need

FTC’s Enforcement Action Against GoodRx Breathes New Life into Decade Old Regulation

Middlemen Running Amok

I wrote about high-priced drugs for years. Then my toddler needed one.

How the FTC's crackdown on GoodRx could impact digital health

With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs

FTC action on PBMs could be just what the doctor ordered to improve patient outcomes

Pharmacy Benefit Managers and the Federal Trade Commission: A Relationship Gone Sour

Everyday High Prices

Progressive lawmakers call on CMS to cull companies with history of Medicare fraud from ACO REACH

How Medicare Advantage plans dodged auditors and overcharged taxpayers by millions

How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 2)

Hidden audits reveal millions in overcharges by Medicare Advantage plans

How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 1)

Federal Trade Commission to Expand Use of Law Against Anticompetitive Practices

‘The Cash Monster Was Insatiable’: How Insurers Exploited Medicare for Billions

Nearly 20% of Medicare Advantage plans lose star revenue for 2023

Anthem must face Medicare Advantage fraud lawsuit, judge rules